 | • レポートコード：D005-08767 • 出版社/出版日：GlobalInfoResearch / 2020年5月22日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、炎症性腸疾患治療薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。炎症性腸疾患治療薬の種類別市場規模（潰瘍性大腸炎、クローン病、不確定大腸炎、その他）、用途別市場規模（アミノサリチル酸、抗生物質、コルチコステロイド、免疫調節剤、生物製剤、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Abbott Laboratories、Quest Medical、Johnson and Johnson、Biocon Ltd、Pfizer、Roche、Takeda Pharmaceutical、Novartis AG、Mylan Pharmaceuticals、Sanofi ・地域別グローバル市場分析 2015年-2020年 ・炎症性腸疾患治療薬の北米市場（アメリカ、カナダ、メキシコ） ・炎症性腸疾患治療薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・炎症性腸疾患治療薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・炎症性腸疾患治療薬の南米市場（ブラジル、アルゼンチン） ・炎症性腸疾患治療薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：潰瘍性大腸炎、クローン病、不確定大腸炎、その他 ・用途別分析：アミノサリチル酸、抗生物質、コルチコステロイド、免疫調節剤、生物製剤、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Inflammatory Bowel Disease Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Inflammatory Bowel Disease Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Inflammatory Bowel Disease Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Inflammatory Bowel Disease Drugs market has been segmented into
Ulcerative Colitis
Crohns Disease
Indeterminate Colitis
Others
By Application, Inflammatory Bowel Disease Drugs has been segmented into:
Amino-salicylates
Antibiotics
Corticosteroids
Immunomodulators
Biologics
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Inflammatory Bowel Disease Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Inflammatory Bowel Disease Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Inflammatory Bowel Disease Drugs market.
The report offers in-depth assessment of the growth and other aspects of the Inflammatory Bowel Disease Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Inflammatory Bowel Disease Drugs Market Share Analysis
Inflammatory Bowel Disease Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Inflammatory Bowel Disease Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Inflammatory Bowel Disease Drugs sales, revenue and market share for each player covered in this report.
The major players covered in Inflammatory Bowel Disease Drugs are:
Abbott Laboratories
Quest Medical
Johnson and Johnson
Biocon Ltd
Pfizer
Roche
Takeda Pharmaceutical
Novartis AG
Mylan Pharmaceuticals
Sanofi
Among other players domestic and global, Inflammatory Bowel Disease Drugs market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Inflammatory Bowel Disease Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Inflammatory Bowel Disease Drugs, with price, sales, revenue and global market share of Inflammatory Bowel Disease Drugs in 2018 and 2019.
Chapter 3, the Inflammatory Bowel Disease Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Inflammatory Bowel Disease Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Inflammatory Bowel Disease Drugs market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Inflammatory Bowel Disease Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Inflammatory Bowel Disease Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Inflammatory Bowel Disease Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Ulcerative Colitis
1.2.3 Crohns Disease
1.2.4 Indeterminate Colitis
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Inflammatory Bowel Disease Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Amino-salicylates
1.3.3 Antibiotics
1.3.4 Corticosteroids
1.3.5 Immunomodulators
1.3.6 Biologics
1.3.7 Others
1.4 Overview of Global Inflammatory Bowel Disease Drugs Market
1.4.1 Global Inflammatory Bowel Disease Drugs Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Abbott Laboratories
2.1.1 Abbott Laboratories Details
2.1.2 Abbott Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Abbott Laboratories SWOT Analysis
2.1.4 Abbott Laboratories Product and Services
2.1.5 Abbott Laboratories Inflammatory Bowel Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Quest Medical
2.2.1 Quest Medical Details
2.2.2 Quest Medical Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Quest Medical SWOT Analysis
2.2.4 Quest Medical Product and Services
2.2.5 Quest Medical Inflammatory Bowel Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Johnson and Johnson
2.3.1 Johnson and Johnson Details
2.3.2 Johnson and Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Johnson and Johnson SWOT Analysis
2.3.4 Johnson and Johnson Product and Services
2.3.5 Johnson and Johnson Inflammatory Bowel Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Biocon Ltd
2.4.1 Biocon Ltd Details
2.4.2 Biocon Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Biocon Ltd SWOT Analysis
2.4.4 Biocon Ltd Product and Services
2.4.5 Biocon Ltd Inflammatory Bowel Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Pfizer
2.5.1 Pfizer Details
2.5.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Pfizer SWOT Analysis
2.5.4 Pfizer Product and Services
2.5.5 Pfizer Inflammatory Bowel Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Roche
2.6.1 Roche Details
2.6.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Roche SWOT Analysis
2.6.4 Roche Product and Services
2.6.5 Roche Inflammatory Bowel Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Takeda Pharmaceutical
2.7.1 Takeda Pharmaceutical Details
2.7.2 Takeda Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Takeda Pharmaceutical SWOT Analysis
2.7.4 Takeda Pharmaceutical Product and Services
2.7.5 Takeda Pharmaceutical Inflammatory Bowel Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Novartis AG
2.8.1 Novartis AG Details
2.8.2 Novartis AG Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Novartis AG SWOT Analysis
2.8.4 Novartis AG Product and Services
2.8.5 Novartis AG Inflammatory Bowel Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Mylan Pharmaceuticals
2.9.1 Mylan Pharmaceuticals Details
2.9.2 Mylan Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Mylan Pharmaceuticals SWOT Analysis
2.9.4 Mylan Pharmaceuticals Product and Services
2.9.5 Mylan Pharmaceuticals Inflammatory Bowel Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Sanofi
2.10.1 Sanofi Details
2.10.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Sanofi SWOT Analysis
2.10.4 Sanofi Product and Services
2.10.5 Sanofi Inflammatory Bowel Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Inflammatory Bowel Disease Drugs Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Inflammatory Bowel Disease Drugs Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Inflammatory Bowel Disease Drugs Manufacturer Market Share in 2019
3.3.2 Top 6 Inflammatory Bowel Disease Drugs Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Inflammatory Bowel Disease Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Inflammatory Bowel Disease Drugs Sales and Market Share by Regions (2015-2020)
4.1.2 Global Inflammatory Bowel Disease Drugs Revenue and Market Share by Regions (2015-2020)
4.2 North America Inflammatory Bowel Disease Drugs Sales and Growth Rate (2015-2020)
4.3 Europe Inflammatory Bowel Disease Drugs Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Inflammatory Bowel Disease Drugs Sales and Growth Rate (2015-2020)
4.5 South America Inflammatory Bowel Disease Drugs Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Inflammatory Bowel Disease Drugs Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Inflammatory Bowel Disease Drugs Sales, Revenue and Market Share by Country
5.1.1 North America Inflammatory Bowel Disease Drugs Sales and Market Share by Country (2015-2020)
5.1.2 North America Inflammatory Bowel Disease Drugs Revenue and Market Share by Country (2015-2020)
5.2 United States Inflammatory Bowel Disease Drugs Sales and Growth Rate (2015-2020)
5.3 Canada Inflammatory Bowel Disease Drugs Sales and Growth Rate (2015-2020)
5.4 Mexico Inflammatory Bowel Disease Drugs Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Inflammatory Bowel Disease Drugs Sales, Revenue and Market Share by Country
6.1.1 Europe Inflammatory Bowel Disease Drugs Sales and Market Share by Country (2015-2020)
6.1.2 Europe Inflammatory Bowel Disease Drugs Revenue and Market Share by Country (2015-2020)
6.2 Germany Inflammatory Bowel Disease Drugs Sales and Growth Rate (2015-2020)
6.3 UK Inflammatory Bowel Disease Drugs Sales and Growth Rate (2015-2020)
6.4 France Inflammatory Bowel Disease Drugs Sales and Growth Rate (2015-2020)
6.5 Russia Inflammatory Bowel Disease Drugs Sales and Growth Rate (2015-2020)
6.6 Italy Inflammatory Bowel Disease Drugs Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Inflammatory Bowel Disease Drugs Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Inflammatory Bowel Disease Drugs Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Inflammatory Bowel Disease Drugs Revenue and Market Share by Regions (2015-2020)
7.2 China Inflammatory Bowel Disease Drugs Sales and Growth Rate (2015-2020)
7.3 Japan Inflammatory Bowel Disease Drugs Sales and Growth Rate (2015-2020)
7.4 Korea Inflammatory Bowel Disease Drugs Sales and Growth Rate (2015-2020)
7.5 India Inflammatory Bowel Disease Drugs Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Inflammatory Bowel Disease Drugs Sales and Growth Rate (2015-2020)
7.7 Australia Inflammatory Bowel Disease Drugs Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Inflammatory Bowel Disease Drugs Sales, Revenue and Market Share by Country
8.1.1 South America Inflammatory Bowel Disease Drugs Sales and Market Share by Country (2015-2020)
8.1.2 South America Inflammatory Bowel Disease Drugs Revenue and Market Share by Country (2015-2020)
8.2 Brazil Inflammatory Bowel Disease Drugs Sales and Growth Rate (2015-2020)
8.3 Argentina Inflammatory Bowel Disease Drugs Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Inflammatory Bowel Disease Drugs Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Inflammatory Bowel Disease Drugs Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Inflammatory Bowel Disease Drugs Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Inflammatory Bowel Disease Drugs Sales and Growth Rate (2015-2020)
9.3 Turkey Inflammatory Bowel Disease Drugs Sales and Growth Rate (2015-2020)
9.4 Egypt Inflammatory Bowel Disease Drugs Sales and Growth Rate (2015-2020)
9.5 South Africa Inflammatory Bowel Disease Drugs Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Inflammatory Bowel Disease Drugs Sales and Market Share by Type (2015-2020)
10.2 Global Inflammatory Bowel Disease Drugs Revenue and Market Share by Type (2015-2020)
10.3 Global Inflammatory Bowel Disease Drugs Price by Type (2015-2020)
11 Global Inflammatory Bowel Disease Drugs Market Segment by Application
11.1 Global Inflammatory Bowel Disease Drugs Sales Market Share by Application (2015-2020)
11.2 Global Inflammatory Bowel Disease Drugs Revenue Market Share by Application (2015-2020)
11.3 Global Inflammatory Bowel Disease Drugs Price by Application (2015-2020)
12 Market Forecast
12.1 Global Inflammatory Bowel Disease Drugs Sales, Revenue and Growth Rate (2021-2025)
12.2 Inflammatory Bowel Disease Drugs Market Forecast by Regions (2021-2025)
12.2.1 North America Inflammatory Bowel Disease Drugs Market Forecast (2021-2025)
12.2.2 Europe Inflammatory Bowel Disease Drugs Market Forecast (2021-2025)
12.2.3 Asia-Pacific Inflammatory Bowel Disease Drugs Market Forecast (2021-2025)
12.2.4 South America Inflammatory Bowel Disease Drugs Market Forecast (2021-2025)
12.2.5 Middle East & Africa Inflammatory Bowel Disease Drugs Market Forecast (2021-2025)
12.3 Inflammatory Bowel Disease Drugs Market Forecast by Type (2021-2025)
12.3.1 Global Inflammatory Bowel Disease Drugs Sales Forecast by Type (2021-2025)
12.3.2 Global Inflammatory Bowel Disease Drugs Market Share Forecast by Type (2021-2025)
12.4 Inflammatory Bowel Disease Drugs Market Forecast by Application (2021-2025)
12.4.1 Global Inflammatory Bowel Disease Drugs Sales Forecast by Application (2021-2025)
12.4.2 Global Inflammatory Bowel Disease Drugs Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Inflammatory Bowel Disease Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Inflammatory Bowel Disease Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Inflammatory Bowel Disease Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table 8. Abbott Laboratories Inflammatory Bowel Disease Drugs Major Business
Table 9. Abbott Laboratories Inflammatory Bowel Disease Drugs Total Revenue (USD Million) (2017-2018)
Table 10. Abbott Laboratories SWOT Analysis
Table 11. Abbott Laboratories Inflammatory Bowel Disease Drugs Product and Services
Table 12. Abbott Laboratories Inflammatory Bowel Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Quest Medical Basic Information, Manufacturing Base and Competitors
Table 14. Quest Medical Inflammatory Bowel Disease Drugs Major Business
Table 15. Quest Medical Inflammatory Bowel Disease Drugs Total Revenue (USD Million) (2017-2018)
Table 16. Quest Medical SWOT Analysis
Table 17. Quest Medical Inflammatory Bowel Disease Drugs Product and Services
Table 18. Quest Medical Inflammatory Bowel Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Johnson and Johnson Basic Information, Manufacturing Base and Competitors
Table 20. Johnson and Johnson Inflammatory Bowel Disease Drugs Major Business
Table 21. Johnson and Johnson Inflammatory Bowel Disease Drugs Total Revenue (USD Million) (2017-2018)
Table 22. Johnson and Johnson SWOT Analysis
Table 23. Johnson and Johnson Inflammatory Bowel Disease Drugs Product and Services
Table 24. Johnson and Johnson Inflammatory Bowel Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Biocon Ltd Basic Information, Manufacturing Base and Competitors
Table 26. Biocon Ltd Inflammatory Bowel Disease Drugs Major Business
Table 27. Biocon Ltd Inflammatory Bowel Disease Drugs Total Revenue (USD Million) (2017-2018)
Table 28. Biocon Ltd SWOT Analysis
Table 29. Biocon Ltd Inflammatory Bowel Disease Drugs Product and Services
Table 30. Biocon Ltd Inflammatory Bowel Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Pfizer Basic Information, Manufacturing Base and Competitors
Table 32. Pfizer Inflammatory Bowel Disease Drugs Major Business
Table 33. Pfizer Inflammatory Bowel Disease Drugs Total Revenue (USD Million) (2017-2018)
Table 34. Pfizer SWOT Analysis
Table 35. Pfizer Inflammatory Bowel Disease Drugs Product and Services
Table 36. Pfizer Inflammatory Bowel Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Roche Basic Information, Manufacturing Base and Competitors
Table 38. Roche Inflammatory Bowel Disease Drugs Major Business
Table 39. Roche Inflammatory Bowel Disease Drugs Total Revenue (USD Million) (2017-2018)
Table 40. Roche SWOT Analysis
Table 41. Roche Inflammatory Bowel Disease Drugs Product and Services
Table 42. Roche Inflammatory Bowel Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Takeda Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 44. Takeda Pharmaceutical Inflammatory Bowel Disease Drugs Major Business
Table 45. Takeda Pharmaceutical Inflammatory Bowel Disease Drugs Total Revenue (USD Million) (2017-2018)
Table 46. Takeda Pharmaceutical SWOT Analysis
Table 47. Takeda Pharmaceutical Inflammatory Bowel Disease Drugs Product and Services
Table 48. Takeda Pharmaceutical Inflammatory Bowel Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 50. Novartis AG Inflammatory Bowel Disease Drugs Major Business
Table 51. Novartis AG Inflammatory Bowel Disease Drugs Total Revenue (USD Million) (2017-2018)
Table 52. Novartis AG SWOT Analysis
Table 53. Novartis AG Inflammatory Bowel Disease Drugs Product and Services
Table 54. Novartis AG Inflammatory Bowel Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Mylan Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 56. Mylan Pharmaceuticals Inflammatory Bowel Disease Drugs Major Business
Table 57. Mylan Pharmaceuticals Inflammatory Bowel Disease Drugs Total Revenue (USD Million) (2017-2018)
Table 58. Mylan Pharmaceuticals SWOT Analysis
Table 59. Mylan Pharmaceuticals Inflammatory Bowel Disease Drugs Product and Services
Table 60. Mylan Pharmaceuticals Inflammatory Bowel Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Sanofi Basic Information, Manufacturing Base and Competitors
Table 62. Sanofi Inflammatory Bowel Disease Drugs Major Business
Table 63. Sanofi Inflammatory Bowel Disease Drugs Total Revenue (USD Million) (2017-2018)
Table 64. Sanofi SWOT Analysis
Table 65. Sanofi Inflammatory Bowel Disease Drugs Product and Services
Table 66. Sanofi Inflammatory Bowel Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Global Inflammatory Bowel Disease Drugs Sales by Manufacturer (2018-2019) (K Units)
Table 68. Global Inflammatory Bowel Disease Drugs Revenue by Manufacturer (2018-2019) (USD Million)
Table 69. Global Inflammatory Bowel Disease Drugs Sales by Regions (2015-2020) (K Units)
Table 70. Global Inflammatory Bowel Disease Drugs Sales Market Share by Regions (2015-2020)
Table 71. Global Inflammatory Bowel Disease Drugs Revenue by Regions (2015-2020) (USD Million)
Table 72. North America Inflammatory Bowel Disease Drugs Sales by Countries (2015-2020) (K Units)
Table 73. North America Inflammatory Bowel Disease Drugs Sales Market Share by Countries (2015-2020)
Table 74. North America Inflammatory Bowel Disease Drugs Revenue by Countries (2015-2020) (USD Million)
Table 75. North America Inflammatory Bowel Disease Drugs Revenue Market Share by Countries (2015-2020)
Table 76. Europe Inflammatory Bowel Disease Drugs Sales by Countries (2015-2020) (K Units)
Table 77. Europe Inflammatory Bowel Disease Drugs Sales Market Share by Countries (2015-2020)
Table 78. Europe Inflammatory Bowel Disease Drugs Revenue by Countries (2015-2020) (USD Million)
Table 79. Asia-Pacific Inflammatory Bowel Disease Drugs Sales by Regions (2015-2020) (K Units)
Table 80. Asia-Pacific Inflammatory Bowel Disease Drugs Sales Market Share by Regions (2015-2020)
Table 81. Asia-Pacific Inflammatory Bowel Disease Drugs Revenue by Regions (2015-2020) (USD Million)
Table 82. South America Inflammatory Bowel Disease Drugs Sales by Countries (2015-2020) (K Units)
Table 83. South America Inflammatory Bowel Disease Drugs Sales Market Share by Countries (2015-2020)
Table 84. South America Inflammatory Bowel Disease Drugs Revenue by Countries (2015-2020) (USD Million)
Table 85. South America Inflammatory Bowel Disease Drugs Revenue Market Share by Countries (2015-2020)
Table 86. Middle East & Africa Inflammatory Bowel Disease Drugs Sales by Countries (2015-2020) (K Units)
Table 87. Middle East & Africa Inflammatory Bowel Disease Drugs Sales Market Share by Countries (2015-2020)
Table 88. Middle East & Africa Inflammatory Bowel Disease Drugs Revenue by Countries (2015-2020) (USD Million)
Table 89. Middle East & Africa Inflammatory Bowel Disease Drugs Revenue Market Share by Countries (2015-2020)
Table 90. Global Inflammatory Bowel Disease Drugs Sales by Type (2015-2020) (K Units)
Table 91. Global Inflammatory Bowel Disease Drugs Sales Share by Type (2015-2020)
Table 92. Global Inflammatory Bowel Disease Drugs Revenue by Type (2015-2020) (USD Million)
Table 93. Global Inflammatory Bowel Disease Drugs Revenue Share by Type (2015-2020)
Table 94. Global Inflammatory Bowel Disease Drugs Sales by Application (2015-2020) (K Units)
Table 95. Global Inflammatory Bowel Disease Drugs Sales Share by Application (2015-2020)
Table 96. Global Inflammatory Bowel Disease Drugs Sales Forecast by Regions (2021-2025) (K Units)
Table 97. Global Inflammatory Bowel Disease Drugs Market Share Forecast by Regions (2021-2025)
Table 98. Global Inflammatory Bowel Disease Drugs Sales Forecast by Type (2021-2025) (K Units)
Table 99. Global Inflammatory Bowel Disease Drugs Market Share Forecast by Type (2021-2025)
Table 100. Global Inflammatory Bowel Disease Drugs Sales Forecast by Application (2021-2025)
Table 101. Global Inflammatory Bowel Disease Drugs Market Share Forecast by Application (2021-2025)
Table 102. Direct Channel Pros & Cons
Table 103. Indirect Channel Pros & Cons
Table 104. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Inflammatory Bowel Disease Drugs Picture
Figure 2. Global Sales Market Share of Inflammatory Bowel Disease Drugs by Type in 2019
Figure 3. Ulcerative Colitis Picture
Figure 4. Crohns Disease Picture
Figure 5. Indeterminate Colitis Picture
Figure 6. Others Picture
Figure 7. Inflammatory Bowel Disease Drugs Sales Market Share by Application in 2018
Figure 8. Amino-salicylates Picture
Figure 9. Antibiotics Picture
Figure 10. Corticosteroids Picture
Figure 11. Immunomodulators Picture
Figure 12. Biologics Picture
Figure 13. Others Picture
Figure 14. Global Inflammatory Bowel Disease Drugs Market Status and Outlook (2015-2025) (USD Million)
Figure 15. United States Inflammatory Bowel Disease Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Canada Inflammatory Bowel Disease Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Mexico Inflammatory Bowel Disease Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Germany Inflammatory Bowel Disease Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 19. France Inflammatory Bowel Disease Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 20. UK Inflammatory Bowel Disease Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Russia Inflammatory Bowel Disease Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Italy Inflammatory Bowel Disease Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 23. China Inflammatory Bowel Disease Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Japan Inflammatory Bowel Disease Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Korea Inflammatory Bowel Disease Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 26. India Inflammatory Bowel Disease Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Southeast Asia Inflammatory Bowel Disease Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Australia Inflammatory Bowel Disease Drugs Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 29. Brazil Inflammatory Bowel Disease Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Egypt Inflammatory Bowel Disease Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Saudi Arabia Inflammatory Bowel Disease Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 32. South Africa Inflammatory Bowel Disease Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 33. Turkey Inflammatory Bowel Disease Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 34. Global Inflammatory Bowel Disease Drugs Sales Market Share by Manufacturer in 2019
Figure 35. Global Inflammatory Bowel Disease Drugs Revenue Market Share by Manufacturer in 2019
Figure 36. Top 3 Inflammatory Bowel Disease Drugs Manufacturer (Revenue) Market Share in 2019
Figure 37. Top 6 Inflammatory Bowel Disease Drugs Manufacturer (Revenue) Market Share in 2019
Figure 38. Key Manufacturer Market Share Trend
Figure 39. Global Inflammatory Bowel Disease Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 40. Global Inflammatory Bowel Disease Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 41. Global Inflammatory Bowel Disease Drugs Revenue Market Share by Regions (2015-2020)
Figure 42. Global Inflammatory Bowel Disease Drugs Revenue Market Share by Regions in 2018
Figure 43. North America Inflammatory Bowel Disease Drugs Sales and Growth Rate (2015-2020)
Figure 44. Europe Inflammatory Bowel Disease Drugs Sales and Growth Rate (2015-2020)
Figure 45. Asia-Pacific Inflammatory Bowel Disease Drugs Sales and Growth Rate (2015-2020)
Figure 46. South America Inflammatory Bowel Disease Drugs Sales and Growth Rate (2015-2020)
Figure 47. Middle East & Africa Inflammatory Bowel Disease Drugs Sales and Growth Rate (2015-2020)
Figure 48. North America Inflammatory Bowel Disease Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 49. North America Inflammatory Bowel Disease Drugs Sales Market Share by Countries (2015-2020)
Figure 50. North America Inflammatory Bowel Disease Drugs Sales Market Share by Countries in 2018
Figure 51. North America Inflammatory Bowel Disease Drugs Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 52. North America Inflammatory Bowel Disease Drugs Revenue Market Share by Countries in 2018
Figure 53. United States Inflammatory Bowel Disease Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 54. Canada Inflammatory Bowel Disease Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 55. Mexico Inflammatory Bowel Disease Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 56. Europe Inflammatory Bowel Disease Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 57. Europe Inflammatory Bowel Disease Drugs Revenue Market Share by Countries (2015-2020)
Figure 58. Europe Inflammatory Bowel Disease Drugs Revenue Market Share by Countries in 2019
Figure 59. Germany Inflammatory Bowel Disease Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 60. UK Inflammatory Bowel Disease Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 61. France Inflammatory Bowel Disease Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 62. Russia Inflammatory Bowel Disease Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Italy Inflammatory Bowel Disease Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 64. Asia-Pacific Inflammatory Bowel Disease Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 65. Asia-Pacific Inflammatory Bowel Disease Drugs Sales Market Share by Regions 2019
Figure 66. Asia-Pacific Inflammatory Bowel Disease Drugs Revenue Market Share by Regions 2019
Figure 67. China Inflammatory Bowel Disease Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 68. Japan Inflammatory Bowel Disease Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 69. Korea Inflammatory Bowel Disease Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 70. India Inflammatory Bowel Disease Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 71. Southeast Asia Inflammatory Bowel Disease Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 72. South America Inflammatory Bowel Disease Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. South America Inflammatory Bowel Disease Drugs Sales Market Share by Countries in 2019
Figure 74. South America Inflammatory Bowel Disease Drugs Revenue Market Share by Countries in 2019
Figure 75. Brazil Inflammatory Bowel Disease Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 76. Argentina Inflammatory Bowel Disease Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Middle East and Africa Inflammatory Bowel Disease Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 78. Middle East and Africa Inflammatory Bowel Disease Drugs Sales Market Share by Countries in 2019
Figure 79. Middle East and Africa Inflammatory Bowel Disease Drugs Revenue Market Share by Countries (2015-2020)
Figure 80. Middle East and Africa Inflammatory Bowel Disease Drugs Revenue Market Share by Countries in 2019
Figure 81. Saudi Arabia Inflammatory Bowel Disease Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 82. Egypt Inflammatory Bowel Disease Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 83. Turkey Inflammatory Bowel Disease Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 84. South Africa Inflammatory Bowel Disease Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 85. Global Inflammatory Bowel Disease Drugs Sales and Growth Rate (2021-2025) (K Units)
Figure 86. Global Inflammatory Bowel Disease Drugs Revenue and Growth Rate (2021-2025) (USD Million)
Figure 87. North America Sales Inflammatory Bowel Disease Drugs Market Forecast (2021-2025) (K Units)
Figure 88. Europe Sales Inflammatory Bowel Disease Drugs Market Forecast (2021-2025) (K Units)
Figure 89. Asia-Pacific Sales Inflammatory Bowel Disease Drugs Market Forecast (2021-2025) (K Units)
Figure 90. South America Sales Inflammatory Bowel Disease Drugs Market Forecast (2021-2025) (K Units)
Figure 91. Middle East & Africa Sales Inflammatory Bowel Disease Drugs Market Forecast (2021-2025) (K Units)
Figure 92. Sales Channel: Direct Channel vs Indirect Channel
下痢を伴う過敏性腸症候群（IBS-D）薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 20…- 便秘薬による過敏性腸症候群の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Irritable Bowel Syndrome with Constipation Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. …
- クローン病治療薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Crohn’s Disease Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Crohn’s Disease Drug mar…
- ライム病ワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Lyme Disease Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Lyme Disease Vaccine mar…
- シャーガス病治療の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Chagas Disease Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.2% in the forecast period of 2020 to 2025 and will expected to reach USD 253.5 million by 2025, from USD 223.8 million in 2019. The Chagas Diseas…